139 related articles for article (PubMed ID: 38004616)
1. N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis.
Kim J; Kang C; Yoo JW; Yoon IS; Jung Y
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004616
[TBL] [Abstract][Full Text] [Related]
2. A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug.
Park S; Kang C; Kim J; Ju S; Yoo JW; Yoon IS; Kim MS; Lee J; Jung Y
Mol Pharm; 2022 Nov; 19(11):3784-3794. PubMed ID: 36043999
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent.
Lee H; Park S; Ju S; Kim S; Yoo JW; Yoon IS; Min DS; Jung Y
Mol Pharm; 2021 Apr; 18(4):1730-1741. PubMed ID: 33661643
[TBL] [Abstract][Full Text] [Related]
4. Colon-Targeted Delivery Facilitates the Therapeutic Switching of Sofalcone, a Gastroprotective Agent, to an Anticolitic Drug via Nrf2 Activation.
Kim W; Kim S; Ju S; Lee H; Jeong S; Yoo JW; Yoon IS; Jung Y
Mol Pharm; 2019 Sep; 16(9):4007-4016. PubMed ID: 31386809
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminosalicylic Acid Azo-Coupled with a GPR109A Agonist Is a Colon-Targeted Anticolitic Codrug with a Reduced Risk of Skin Toxicity.
Jeong S; Lee H; Kim S; Ju S; Kim W; Cho H; Kim HY; Heo G; Im E; Yoo JW; Yoon IS; Jung Y
Mol Pharm; 2020 Jan; 17(1):167-179. PubMed ID: 31743034
[TBL] [Abstract][Full Text] [Related]
6. A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Yang Y; Kim W; Kim D; Jeong S; Yoo JW; Jung Y
Drug Des Devel Ther; 2019; 13():231-242. PubMed ID: 30643389
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
Kim W; Nam J; Lee S; Jeong S; Jung Y
Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis.
Kim W; Kim D; Jeong S; Ju S; Lee H; Kim S; Yoo JW; Yoon IS; Jung Y
Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31703411
[TBL] [Abstract][Full Text] [Related]
10. A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats.
Kim S; Lee S; Lee H; Ju S; Park S; Kwon D; Yoo JW; Yoon IS; Min DS; Jung YS; Jung Y
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32899177
[TBL] [Abstract][Full Text] [Related]
11. Dapsone Azo-Linked with Two Mesalazine Moieties Is a "Me-Better" Alternative to Sulfasalazine.
Kang C; Kim J; Ju S; Park S; Yoo JW; Yoon IS; Kim MS; Jung Y
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336057
[TBL] [Abstract][Full Text] [Related]
12. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
[TBL] [Abstract][Full Text] [Related]
13. Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.
Llorente X; Esteruelas G; Bonilla L; Agudelo MG; Filgaira I; Lopez-Ramajo D; Gong RC; Soler C; Espina M; García ML; Manils J; Pujol M; Sánchez-López E
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175765
[TBL] [Abstract][Full Text] [Related]
14. Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment.
Esteruelas G; Halbaut L; García-Torra V; Espina M; Cano A; Ettcheto M; Camins A; Souto EB; Luisa García M; Sánchez-López E
Int J Pharm; 2022 Jan; 612():121379. PubMed ID: 34915146
[TBL] [Abstract][Full Text] [Related]
15. An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists.
Citraro R; Bosco F; Di Gennaro G; Tallarico M; Guarnieri L; Gallelli L; Rania V; Siniscalchi A; De Sarro G; Leo A
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514193
[TBL] [Abstract][Full Text] [Related]
16. Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A.
Kang C; Kim J; Ju S; Cho H; Kim HY; Yoon IS; Yoo JW; Jung Y
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678670
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug.
Sadeghi F; Eidizade A; Saremnejad F; Hadizadeh F; Khodaverdi E; Akhgari A
Iran J Basic Med Sci; 2020 Jun; 23(6):781-787. PubMed ID: 32695295
[TBL] [Abstract][Full Text] [Related]
19. Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis.
Kong H; Lee Y; Hong S; Han J; Choi B; Jung Y; Kim YM
J Drug Target; 2009 Jul; 17(6):450-8. PubMed ID: 19527116
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target.
Lee S; Lee Y; Kim W; Nam J; Jeong S; Yoo JW; Kim MS; Moon HR; Jung Y
Drug Des Devel Ther; 2015; 9():4227-37. PubMed ID: 26300626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
